AVEO Oncology (AVEO) Reports Q3 Loss of $0.22/Share

AVEO Oncology (NASDAQ: AVEO) reported Q3 EPS of ($0.22), versus ($0.07) reported last year. Revenue for the quarter came in at $4.61 million, versus $992 thousand reported last year.

For earnings history and earnings-related data on AVEO Oncology (AVEO) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Zeo Energy Corp (ZEO) Misses Q2 EPS by 7c
• JD.com (JD) Reiterated at Buy by Benchmark Amid Earnings Recovery